Prodrugs of fused-bicyclic C5aR antagonists
The present disclosure provides, inter alia, Compounds of Formulae IA, IB, IC, IIA, IIB and IIC or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders invo...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
21.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides, inter alia, Compounds of Formulae IA, IB, IC, IIA, IIB and IIC or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications. |
---|---|
Bibliography: | Application Number: US201916982817 |